Skip to main content
Log in

Usefulness of ferroxidase activity of ceruloplasmin in the diagnosis of Wilson’s disease

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Serum ceruloplasmin is one of the most commonly used screening tests for Wilson’s disease. However immunological assays for ceruloplasmin are not recommended for diagnosis and management of Wilson’s disease through calculation of free copper index. Enzymatic methods using non-physiological substrates have toxicity and stability problems, making them difficult to automate. Ferroxidase assays may be a satisfactory alternative for measuring serum ceruloplasmin. The o-dianisidine hydrochloride manual method for estimation of serum ceruloplasmin enzyme activity was compared with an automated method using the ferroxidase activity of ceruloplasmin in measurement in a double blind study in 91 consecutive patients screened for Wilson’s disease. The o-dianisidine and ferroxidase methods both successfully identified 7 patients with Wilson’s disease. Values for these 7 patients in the o-dianisidine and ferroxidase methods were median 5.0 (range 0–16.0 U/L) and median 45.0 (range 4–166 U/L) respectively. There were 7 other positive values (<62 U/L) with the o-diansidine method and 2 (<200 U/L) with the ferroxidase method, where WD was not confirmed. ROC curves for both methods showed area under the curve of 0.998 for o-dianisidine and 0.997 for ferroxidase. Using literature cut off values of 62 U/L and 200 U/L respectively both methods had 100% sensitivity and specificity was 91.7% (o-dianisidine) and 97.6% (ferroxidase). For the o-dianisidine assay, specificity was improved to 98.8% using a cut off of 22.5 U/L. In the 84 persons (46 adults and 38 children) in whom the diagnosis of Wilson’s disease was not established, the mean value for ceruloplasmin activity by the o-dianisidine and ferroxidase methods was 124.7 ± 48.7 U/L and 571.4 ± 168.1 U/L respectively. There were no significant differences between sex or age of patients (p > 0.29). In a subsequent evaluation with 372 specimens, the Pearson correlation coefficient between the assays was 0.908, p < 0.01, slope 4.06, intercept 265.8, with the manual assay as the x-axis. The ferroxidase assay is a suitable replacement for the o-dianisidine assay in detecting patients with Wilson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Walshe JM. Wilson’s disease: the importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem 2003; 40; 115–121.

    Article  PubMed  CAS  Google Scholar 

  2. Ferenci P. Wilson’s Disease. Clin Gastro Hepatol 2005; 3:726–733

    Article  CAS  Google Scholar 

  3. Lehmann HP, Schosinsky KH, Beeler MF. Measurement of Ceruloplasmin from its oxidase activity in serum by use of o-Dianisidine Dihydrochloride. Clin Chem 1974; 20: 1556–1563.

    PubMed  Google Scholar 

  4. Lehmann HP, Schosinsky KH, Beeler MF. Standardization of serum Ceruloplasmin concentrations in international enzyme units with o-Dianisidine Dihydrochloride as substrate. Clin Chem 1974; 20: 1564–1567.

    PubMed  CAS  Google Scholar 

  5. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1965; 241: 2746–2751.

    Google Scholar 

  6. Mukerjee H. A kinetic method for determination of serum ceruloplasmin. Clin Chem 1990; 36: 391–392.

    PubMed  CAS  Google Scholar 

  7. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998; 44: 2313–2319.

    PubMed  CAS  Google Scholar 

  8. Jones RG, Paynes RB. Clinical investigation and Statistics in laboratory Medicine. ACB Venture Publications, London 1997: p35.

    Google Scholar 

  9. Shiomo Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, et al. Iron accumulation in the liver of patients with Wilson’s disease. Am J Gastroent 2001; 96: 3147–3151.

    Article  Google Scholar 

  10. Somani BL, Ambade V. Novel composition for kinetic assay of ceruloplasmin. Clin Chem 2005; 51(Suppl A90): B–127.

    Google Scholar 

  11. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Relationship between serum copper, ceruloplasmin and non-caeruloplasmin bound copper in routine clinical practice. Clin Chem 2005; 51: 1558–1559.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. J. Fleming.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleming, J.J., Santhosh, S., Selvakumar, R. et al. Usefulness of ferroxidase activity of ceruloplasmin in the diagnosis of Wilson’s disease. Indian J Clin Biochem 24, 15–22 (2009). https://doi.org/10.1007/s12291-009-0003-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-009-0003-4

Key Words

Navigation